Case Report: SMARCA4 (BRG1)-deficient undifferentiated carcinoma of gallbladder with genetic analysis

被引：3
|
作者：
Meng, Xiangpeng [1 ]
Ma, Jia [2 ]
Meng, Nan [3 ]
Yun, Tianyu [3 ]
Niu, Beifang [3 ,4 ,5 ]
机构：
[1] China Med Univ, Pancreat Endocrinol Ward, Dept Gen Surg, Shengjing Hosp, Shenyang, Peoples R China
[2] China Med Univ, Affiliated Hosp 4, Dept Gastroenterol, Shenyang, Peoples R China
[3] Beijing ChosenMed Clin Lab Co Ltd, Beijing, Peoples R China
[4] Chinese Acad Sci, Comp Network Informat Ctr, Beijing, Peoples R China
[5] Univ Chinese Acad Sci, Beijing, Peoples R China
来源：
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
关键词：
SMARCA4; BRG1; SWI; SNF; gallbladder carcinoma; case report; SMALL-CELL CARCINOMA; SWI/SNF COMPLEX; FANCONI-ANEMIA; PIK3CA MUTATIONS; CANCER; EXPRESSION; OVARY; INHIBITION; RISK; GAIN;
D O I：
10.3389/fonc.2023.1086266
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SMARCA4 (BRG1)-deficient undifferentiated carcinoma is a rare and highly aggressive malignancy. It has been reported to occur in a multiple range of organs. However, to the best of our knowledge, SMARCA4 (BRG1)-deficient undifferentiated carcinoma of gallbladder has not yet been reported. Here, we describe a case of SMARCA4 (BRG1)-deficient undifferentiated carcinoma of gallbladder. Through comprehensive genetic analysis, we hypothesized that in addition to SMARCA4 (BRG1) deficiency, other genetic changes might also be involved in the tumorigenesis of undifferentiated gallbladder cancer in this patient, particularly somatic mutations in the CTNNB1, KRAS, PIK3CA, TP53, CREBBP, and FANCI genes. To the best of our knowledge, this is the first report of SMARCA4 (BRG1)-deficient undifferentiated carcinoma of gallbladder with genetic analysis.
引用
收藏
页数：7
相关论文
共 50 条
  • [41] SWI/SNF chromatin remodeling subunit Smarca4/BRG1 is essential for female fertility†
    Abedini, Atefeh
    Landry, David A.
    Macaulay, Angus D.
    Vaishnev, Het
    Parbhakar, Ashna
    Ibrahim, Dalia
    Salehi, Reza
    Maranda, Vincent
    Macdonald, Elizabeth
    Vanderhyden, Barbara C.
    BIOLOGY OF REPRODUCTION, 2023, 108 (02) : 279 - 291
  • [42] SMARCA4 (BRG1) activates ABCC3 transcription to promote hepatocellular carcinogenesis
    Liu, Huimin
    Yue, Linbo
    Hong, Wenxuan
    Zhou, Junjing
    LIFE SCIENCES, 2024, 347
  • [43] Development of novel, selective SMARCA2 (BRM) degraders for treatment of SMARCA4 (BRG1) mutated tumors
    Mazan, Andrzej
    Wrobel, Anna
    Dreas, Agnieszka
    Radzimierski, Adam
    Michalik, Kinga
    Kowal, Anna
    Wiklik, Katarzyna
    Wnuk-Lipinska, Katarzyna
    Niedziejko, Paulina
    Kozlowska, Kamila
    Losko, Magdalena
    Szczesniak, Joanna
    Sroka-Porada, Agnieszka
    Martyka, Justyna
    Kulesza, Urszula
    Zuchowicz, Karol
    Zastawna, Magdalena
    Alvarez, Jose
    Stasi, Luigi
    Littlewood, Peter
    Rzymski, Tomasz
    Brzozka, Krzysztof
    CANCER RESEARCH, 2020, 80 (16)
  • [44] The role of chromatin remodeler SMARCA4/BRG1 in brain cancers: a potential therapeutic target
    Sophie M. Navickas
    Katherine A. Giles
    Kate H. Brettingham-Moore
    Phillippa C. Taberlay
    Oncogene, 2023, 42 : 2363 - 2373
  • [45] Additional Considerations on Aberrant BRG1 (SMARCA4) Expression in Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT)
    Cyrta, Joanna
    Brillet, Riwan
    Laas, Enora
    Just, Pierre-Alexandre
    Andrianteranagna, Mamy
    Leary, Alexandra
    Vincent-Salomon, Anne
    Bourdeaut, Franck
    Masliah-Planchon, Julien
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2024, 48 (10) : 1335 - 1338
  • [46] SMARCA4(BRG1) and SMARCB1(INI1) Immunoexpression in TTF1 Negative Neuroendocrine Carcinoma
    Alnoor, Fnu
    Gandhi, Jatin
    Solares, Jorge
    Gradowski, Joel
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 816 - 817
  • [47] Discovery of selective BRM ( SMARCA2) ATPase inhibitors for the treatment of BRG1 (SMARCA4) mutant cancers
    Lee, Janice Y.
    Brooks, Nathan
    Antonakos, Brandon
    Perria, Bryan
    Langan, Candace
    Jones, Bonita D.
    Flack, Robert Stephen
    Li, Zhifang
    Terry, David
    Wallace, Ross
    Bondi, Robert
    Sis, Gereint
    Baracani, Ronee
    McVean, Maralee
    Kolakowski, Gabrielle
    Osimboni, Dayo
    Wilson, Kevin
    CANCER RESEARCH, 2024, 84 (06)
  • [48] Residual Complexes Containing SMARCA2 (BRM) Underlie the Oncogenic Drive of SMARCA4 (BRG1) Mutation
    Wilson, Boris G.
    Helming, Katherine C.
    Wang, Xiaofeng
    Kim, Youngha
    Vazquez, Francisca
    Jagani, Zainab
    Hahn, William C.
    Roberts, Charles W. M.
    MOLECULAR AND CELLULAR BIOLOGY, 2014, 34 (06) : 1136 - 1144
  • [49] The role of chromatin remodeler SMARCA4/BRG1 in brain cancers: a potential therapeutic target
    Navickas, Sophie M.
    Giles, Katherine A.
    Brettingham-Moore, Kate H.
    Taberlay, Phillippa C.
    ONCOGENE, 2023, 42 (31) : 2363 - 2373
  • [50] Dermatofibrosarcoma Protuberans and SMARCA4/BRG1 Loss: Novel Molecular Change or Coincidental Association?
    Deng, Huiyan
    Li, Mingyang
    Jia, Ying
    Jiang, Hanxu
    Jia, Keqi
    Fan, Xiaojie
    Liu, Yueping
    SAGE OPEN PATHOLOGY, 2025, 18
12345